Paracrine stimulation of endothelial cell motility and angiogenesis by platelet-derived deoxyribose-1-phosphate

Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2631-8. doi: 10.1161/ATVBAHA.110.215855. Epub 2010 Sep 30.

Abstract

Objective: Micromolar concentrations of the proangiogenic metabolite deoxyribose-1-phosphate (dRP) were detected in platelet supernatants by mass spectrometry. In this study, we assessed whether the release of dRP by platelets stimulates endothelial cell migration and angiogenesis.

Methods and results: Protein-free supernatants from thrombin-stimulated platelets increased human umbilical vein endothelial cell migratory activity in transmigration and monolayer repair assays. This phenomenon was ablated by genetic silencing of dRP-generating uridine phosphorylase (UP) and thymidine phosphorylase (TP) or pharmacological inhibition of UP and restored by exogenous dRP. The stimulation of endothelial cell migration by platelet-derived dRP correlated with upregulation of integrin β(3), which was induced in a reactive oxygen species-dependent manner, and was mediated by the activity of the integrin heterodimer α(v)β(3). The physiological relevance of dRP release by platelets was confirmed in a chick chorioallantoic membrane assay, where the presence of this metabolite in platelet supernatants strongly induced capillary formation.

Conclusions: Platelet-derived dRP stimulates endothelial cell migration by upregulating integrin β(3) in a reactive oxygen species-dependent manner. As demonstrated by our in vivo experiments, this novel paracrine regulatory pathway is likely to play an important role in the stimulation of angiogenesis by platelets.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Platelets / drug effects
  • Blood Platelets / metabolism*
  • Cell Movement* / drug effects
  • Cells, Cultured
  • Chick Embryo
  • Chorioallantoic Membrane / blood supply*
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Gas Chromatography-Mass Spectrometry
  • Gene Silencing
  • Humans
  • Integrin alphaV / metabolism
  • Integrin alphaVbeta3 / metabolism
  • Integrin beta3 / metabolism
  • Neovascularization, Physiologic* / drug effects
  • Paracrine Communication* / drug effects
  • Reactive Oxygen Species / metabolism
  • Ribosemonophosphates / metabolism*
  • Thrombin / metabolism
  • Thymidine Phosphorylase / antagonists & inhibitors
  • Thymidine Phosphorylase / genetics
  • Thymidine Phosphorylase / metabolism
  • Time Factors
  • Uridine Phosphorylase / antagonists & inhibitors
  • Uridine Phosphorylase / genetics
  • Uridine Phosphorylase / metabolism

Substances

  • Enzyme Inhibitors
  • ITGB3 protein, human
  • Integrin alphaV
  • Integrin alphaVbeta3
  • Integrin beta3
  • Reactive Oxygen Species
  • Ribosemonophosphates
  • Uridine Phosphorylase
  • TYMP protein, human
  • Thymidine Phosphorylase
  • Thrombin